Farmacia e farmacoloxía

2024

1. 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives

   Molecules, Vol. 29, Núm. 11

2. A journey through the history of PEGylated drug delivery nanocarriers

   Drug Delivery and Translational Research, Vol. 14, Núm. 8, pp. 2026-2031

3. A translational framework to DELIVER nanomedicines to the clinic

   Nature Nanotechnology, Vol. 19, Núm. 11, pp. 1597-1611

4. Agreement between pharmacists and physicians on the assessment of appropriateness of antimicrobial prescribing

   Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 10, pp. 546-554

5. Artificial Intelligence and Machine Learning Applications to Pharmacokinetic Modeling and Dose Prediction of Antibiotics: A Scoping Review

   Antibiotics, Vol. 13, Núm. 12

6. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

   Vaccines, Vol. 12, Núm. 1

7. Biocompatibility Testing of UV-Curable Polydimethylsiloxane for Human Umbilical Vein Endothelial Cell Culture on-a-Chip

   ACS Omega, Vol. 9, Núm. 28, pp. 30281-30293

8. Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers

   European Journal of Pharmaceutics and Biopharmaceutics, Vol. 199

9. Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study

   International Journal of Molecular Sciences, Vol. 25, Núm. 18

10. Clinical usefulness of serum angiotensin converting enzyme in silicosis

    Pulmonology, Vol. 30, Núm. 4, pp. 370-377

11. Comparación de la calidad de vida en personas que viven con infección por VIH en seguimiento mediante atención farmacéutica según metodología capacidad motivación-oportunidad vs. seguimiento convencional. Proyecto MAS-VIH

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 149-157

12. Continuidad asistencial entre cardiología y AP en pacientes con cardiopatía isquémica crónica: diseño del estudio CAPRICI

    REC: CardioClinics

13. Controlling the protein corona of polymeric nanocapsules: effect of polymer shell on protein adsorption

    Drug Delivery and Translational Research, Vol. 14, Núm. 4, pp. 918-933

14. Cost-effectiveness analysis of subcutaneous biosimilar tocilizumab in patients with rheumatoid arthritis in Spain

    Farmacia Hospitalaria

15. Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

    Diseases, Vol. 12, Núm. 10

16. Design, synthesis and validation of a new Crimped Head-Piece for DNA-Encoded libraries generation

    Bioorganic and Medicinal Chemistry, Vol. 99

17. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

18. Effect of Bulky N-Dibenzofuranylmethyl Substitution on the 5-HT2 Receptor Affinity and Efficacy of a Psychedelic Phenethylamine

    ACS Chemical Neuroscience, Vol. 15, Núm. 3, pp. 608-616

19. Effectiveness and safety of pembrolizumab as first-line treatment for non-small cell lung cancer in real clinical practice

    Journal of Oncology Pharmacy Practice

20. Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllers

    Frontiers in Immunology, Vol. 15